Home
Valuation

Work Area: Valuation

South Korea’s IP-backed lending market growth exceeds targets

Although heavy reliance on government-backed initiatives creates uncertain future for IP holders

‘Live or die’: LG Chem prepares to launch series of disputes as strategy pivots, reveals IP head

The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min

JS Held expands Ocean Tomo IP practice with new acquisition

The global scientific and engineering consultancy has bought TechPats, a patent-focused technical expert firm, at a time when an uncertain economy and declining number of M&As has led some companies to issue layoff notices to IP staff

Latest content

In Blackberry patent sale, Canada sees loss of prestige not value creation opportunity

Possible deal comes during a period of concern in the country over loss of tech crown jewels, engineering talent and the bleeding of IP assets

20 November 2020

Your guide to covid-19 vaccine stakeholders’ IP strategies

IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations

19 November 2020

Data is the new frontier in healthcare IP licensing, says award-winning TTO

IAM speaks to the tech transfer office of Oregon Health & Science University about the keys to success in university-industry deal-making

17 November 2020

Under sanctions pressure, Huawei sells off entry level smartphone brand to government

Company has sold its Honor handset unit to a consortium backed by local authorities in Shenzhen government, a move that will take a big chunk out of its sales figures

17 November 2020

There has never been a better time to sell or buy drug royalties, says industry veteran

IAM speaks to leading deal-maker David MacNaughtan about his new fund and the growth of this form of life sciences IP monetisation

10 November 2020

Pfizer’s covid vaccine found 90% effective, but raises IP questions

Company CEO proclaims “a great day for science and humanity”, but there are patent, know-how and data uncertainties to overcome

09 November 2020

Meet the IV veteran creating an IP licensing business in the pharma space

Connie Wan of Seattle Gummy Company talks to IAM about the lessons she learned at the mega-NPE

06 November 2020

Elite patent stocks fell in September but outperformed NASDAQ

The composite stock performance of the IAM/ktMINE US Patent Elite dipped though not by as much as most major exchanges

05 November 2020

CEO’s patent comments illustrate high stakes of LG Chem IP campaign

The company plans to spin off its lucrative auto battery business, and executive says patents will be key to fending off competition from China

04 November 2020

The brokered patent market in 2020

Featured in Secondary Market Activity

As a drop in corporate buying is matched by a rise in NPE activity, it is time to keep your friends close and your defensive aggregators closer

04 November 2020

Unlock unlimited access to all IAM content